生薬甘草の心臓への電気薬理学的作用: in vitroとin vivoモデルを用いた統合的解析

Background: Some Kampo preparations, which are made from licorice containing glycyrrhizic acid (GZA) of ≥2%, have been used for treating patients with palpitation; however, it is not fully understood how licorice may control it. Methods: Exp 1: Glycyrrhetinic acid (GRA), a major hydrolyzed metabolit...

Full description

Saved in:
Bibliographic Details
Published in日本薬理学会年会要旨集 p. 1-O-D3-4
Main Authors 長澤(萩原), 美帆子, 杉山, 篤, 千葉, 浩輝, 神林, 隆一, 川合, 眞一, 布井, 啓雄, 後藤, 愛, 中瀬古(泉), 寛子, 武井, 義則, 松本, 明郎
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本薬理学会 2021
Subjects
Online AccessGet full text
ISSN2435-4953
DOI10.1254/jpssuppl.94.0_1-O-D3-4

Cover

More Information
Summary:Background: Some Kampo preparations, which are made from licorice containing glycyrrhizic acid (GZA) of ≥2%, have been used for treating patients with palpitation; however, it is not fully understood how licorice may control it. Methods: Exp 1: Glycyrrhetinic acid (GRA), a major hydrolyzed metabolite of orally taken GZA, at 0.1, 1 and 10 μg/mL was cumulatively applied to human induced pluripotent stem cell-derived cardiomyocytes sheets (n=6).  Exp 2: Kanzoto, 6.0 g of which contains a decoction made of 8.0 g licorice, in a dose of 2 or 6 g/body/day was orally administered to conscious chronic atrioventricular block dogs for 3 consecutive days (n=4), and Holter electrocardiographic monitoring was performed before 1st dosing and on the 3rd day of dosing. Results: Exp 1: GRA prolonged the effective refractory period in rate- and concentration-dependent manners and delayed the conduction within initial 300 μm from the pacing site in the sheets, indicating its Na+ channel blockade with rapid dissociation. Exp 2: The high dose suppressed sinoatrial and idioventricular automaticity without slowing intraventricular conduction, and caused cardiac arrest in 1 out of 4 dogs, which was not induced by the low dose.Conclusion: Licorice may possess lidocaine-like Na+ channel blocking property, which will partly explain its clinical utility.
Bibliography:94_1-O-D3-4
ISSN:2435-4953
DOI:10.1254/jpssuppl.94.0_1-O-D3-4